Assessing Florbetaben PET Patterns in MCI Patients for an Improved Prediction of Conversion to AD.

Trial Profile

Assessing Florbetaben PET Patterns in MCI Patients for an Improved Prediction of Conversion to AD.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 27 Dec 2017

At a glance

  • Drugs Florbetaben F18 (Primary)
  • Indications Alzheimer's disease
  • Focus Diagnostic use
  • Most Recent Events

    • 27 Dec 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top